查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386359

口乾症治療市場報告：2030 年趨勢、預測與競爭分析

Xerostomia Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

口乾症治療的趨勢與預測

預計到 2030 年，全球口乾症治療市場將達到約 11 億美元，2024 年至 2030 年複合年成長率為 3.5%。該市場的主要促進因素是對口乾症治療的需求不斷成長、新型和創新性口乾症治療的市場開拓不斷增加以及對口乾症的認知不斷提高。全球口乾症藥物市場的未來看起來充滿希望，有成藥和處方藥應用的機會。

口乾症治療市場洞察

Lucintel 預測，人造唾液的使用量將更高，因為其表現與天然唾液相似，預計在預測期內將出現最高成長。

由於人口口乾病例增加以及該地區先進治療方案的可用性，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球口乾症治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球口乾症治療市場趨勢（2018-2023）與預測（2024-2030）
  • 依產品類型分類的全球口乾症治療市場
    • 人工唾液
    • 牙膏
    • Salivary Stimulants
    • 唾液替代品
    • 藥物
    • 唾液筆
  • 全球口乾症治療市場（依應用）
    • 在商店
    • 處方箋

第4章 2018-2030年區域市場趨勢及預測分析

  • 依地區分類的全球口乾症治療市場
  • 北美口乾症治療市場
  • 歐洲口乾症治療市場
  • 亞太地區口乾症治療市場
  • 其他區域性口乾症治療市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依產品類型分類的全球口乾症治療市場成長機會
    • 全球口乾症治療市場成長機會（依應用）
    • 全球口乾症治療市場成長機會（依地區）
  • 全球口乾症治療市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球口乾症治療市場的產能
    • 全球口乾症治療市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • GlaxoSmithKline
  • Church & Dwight
  • Colgate-Palmolive
  • Hikma Pharmaceuticals
  • Pendopharm
  • Sun Pharmaceuticals
  • Lupin Pharmaceuticals
  • Pfizer
  • Parnell Pharmaceuticals
  • Acacia Pharma
簡介目錄

Xerostomia Therapeutic Trends and Forecast

The future of the global xerostomia therapeutic market looks promising with opportunities in the over the counter and prescription applications. The global xerostomia therapeutic market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are growing demand for xerostomia treatments, rising development of new and innovative xerostomia treatments, and increasing awareness of xerostomia.

A more than 150-page report is developed to help in your business decisions.

Xerostomia Therapeutic by Segment

The study includes a forecast for the global xerostomia therapeutic by product type, application, and region.

Xerostomia Therapeutic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Artificial Saliva
  • Dentifrices
  • Salivary Stimulants
  • Saliva Substitutes
  • Drugs
  • Salivary Pen

Xerostomia Therapeutic Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Over The Counter
  • Prescription

Xerostomia Therapeutic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Xerostomia Therapeutic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies xerostomia therapeutic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the xerostomia therapeutic companies profiled in this report include-

  • GlaxoSmithKline
  • Church & Dwight
  • Colgate-Palmolive
  • Hikma Pharmaceuticals
  • Pendopharm
  • Sun Pharmaceuticals
  • Lupin Pharmaceuticals
  • Pfizer
  • Parnell Pharmaceuticals
  • Acacia Pharma

Xerostomia Therapeutic Market Insights

Lucintel forecasts that artificial saliva is expected to witness highest growth over the forecast period due to its significant usage to perform similarly to natural saliva.

North America is expected to witness highest growth over the forecast period due to the growing cases of dry mouth among population and availability of advanced treatment options in the region.

Features of the Global Xerostomia Therapeutic Market

Market Size Estimates: Xerostomia therapeutic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Xerostomia therapeutic market size by product type, application, and region in terms of value ($B).

Regional Analysis: Xerostomia therapeutic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the xerostomia therapeutic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the xerostomia therapeutic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the xerostomia therapeutic market size?

Answer: The global xerostomia therapeutic market is expected to reach an estimated $1.1 billion by 2030.

Q.2 What is the growth forecast for xerostomia therapeutic market?

Answer: The global xerostomia therapeutic market is expected to grow with a CAGR of 3.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the xerostomia therapeutic market?

Answer: The major drivers for this market are growing demand for xerostomia treatments, rising development of new and innovative xerostomia treatments, and increasing awareness of xerostomia.

Q4. What are the major segments for xerostomia therapeutic market?

Answer: The future of the xerostomia therapeutic market looks promising with opportunities in the over the counter and prescription applications.

Q5. Who are the key xerostomia therapeutic market companies?

Answer: Some of the key xerostomia therapeutic companies are as follows:

  • GlaxoSmithKline
  • Church & Dwight
  • Colgate-Palmolive
  • Hikma Pharmaceuticals
  • Pendopharm
  • Sun Pharmaceuticals
  • Lupin Pharmaceuticals
  • Pfizer
  • Parnell Pharmaceuticals
  • Acacia Pharma

Q6. Which xerostomia therapeutic market segment will be the largest in future?

Answer: Lucintel forecasts that artificial saliva is expected to witness highest growth over the forecast period due to its significant usage to perform similarly to natural saliva.

Q7. In xerostomia therapeutic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the growing cases of dry mouth among population and availability of advanced treatment options in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the xerostomia therapeutic market by product type (artificial saliva, dentifrices, salivary stimulants, saliva substitutes, drugs, and salivary pen), application (over the counter and prescription), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Xerostomia Therapeutic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Xerostomia Therapeutic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Xerostomia Therapeutic Market by Product Type
    • 3.3.1: Artificial Saliva
    • 3.3.2: Dentifrices
    • 3.3.3: Salivary Stimulants
    • 3.3.4: Saliva Substitutes
    • 3.3.5: Drugs
    • 3.3.6: Salivary Pen
  • 3.4: Global Xerostomia Therapeutic Market by Application
    • 3.4.1: Over The Counter
    • 3.4.2: Prescription

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Xerostomia Therapeutic Market by Region
  • 4.2: North American Xerostomia Therapeutic Market
    • 4.2.2: North American Xerostomia Therapeutic Market by Application: Over The Counter and Prescription
  • 4.3: European Xerostomia Therapeutic Market
    • 4.3.1: European Xerostomia Therapeutic Market by Product Type: Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen
    • 4.3.2: European Xerostomia Therapeutic Market by Application: Over The Counter and Prescription
  • 4.4: APAC Xerostomia Therapeutic Market
    • 4.4.1: APAC Xerostomia Therapeutic Market by Product Type: Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen
    • 4.4.2: APAC Xerostomia Therapeutic Market by Application: Over The Counter and Prescription
  • 4.5: ROW Xerostomia Therapeutic Market
    • 4.5.1: ROW Xerostomia Therapeutic Market by Product Type: Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen
    • 4.5.2: ROW Xerostomia Therapeutic Market by Application: Over The Counter and Prescription

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Xerostomia Therapeutic Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Xerostomia Therapeutic Market by Application
    • 6.1.4: Growth Opportunities for the Global Xerostomia Therapeutic Market by Region
  • 6.2: Emerging Trends in the Global Xerostomia Therapeutic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Xerostomia Therapeutic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Xerostomia Therapeutic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Church & Dwight
  • 7.3: Colgate-Palmolive
  • 7.4: Hikma Pharmaceuticals
  • 7.5: Pendopharm
  • 7.6: Sun Pharmaceuticals
  • 7.7: Lupin Pharmaceuticals
  • 7.8: Pfizer
  • 7.9: Parnell Pharmaceuticals
  • 7.10: Acacia Pharma